Valproic Acid Is Not a Substrate for P-glycoprotein or Multidrug Resistance Proteins 1 and 2 in a Number of in Vitro and in Vivo Transport Assays

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2007-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.106.102491PMID 17043155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.

  2007influential reference
• Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.

  2006cited by this paper
• Differential in Vivo Sensitivity to Inhibition of P-glycoprotein Located in Lymphocytes, Testes, and the Blood-Brain Barrier

  2006cited by this paper
• Lack of Interactions between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents

  2006cited by this paper
• Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms

  2005cited by this paper
• Expression of Multidrug Transporters MRP1, MRP2, and BCRP Shortly after Status Epilepticus, during the Latent Period, and in Chronic Epileptic Rats

  2005cited by this paper
• Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.

  2005cited by this paper
• Facilitating acute stroke recovery with magnetic fields?

  2005cited by this paper
• Refractory Generalised Convulsive Status Epilepticus

  2005cited by this paper
• Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

  2005influential reference
• Efficacy of rapid IV administration of valproic acid for status epilepticus

  2005cited by this paper
• Drug resistance in brain diseases and the role of drug efflux transporters

  2005influential reference
• Efficacy of rapid IV administration of valproic acid for status epilepticus

  2005cited by this paper
• Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.

  2004influential reference
• Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats

  2004cited by this paper
• Abolition of Valproate-Derived Choleresis in the Mrp2 Transporter-Deficient Rat

  2004influential reference
• Development and characterization of a recombinant madin-darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1)

  2004cited by this paper
• The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions

  2004cited by this paper
• Importance of P-glycoprotein at blood-tissue barriers.

  2004cited by this paper
• A Fluorometric Screening Assay for Drug Efflux Transporter Activity in the Blood-Brain Barrier

  2004influential reference
• Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry.

  2004cited by this paper
• Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.

  2004cited by this paper
• Drug efflux transporters in the CNS.

  2003cited by this paper
• Multidrug Resistance Protein MRP2 Contributes to Blood-Brain Barrier Function and Restricts Antiepileptic Drug Activity

  2003cited by this paper
• Widespread Upregulation of Drug‐resistance Proteins in Fatal Human Status Epilepticus

  2003cited by this paper
• Mechanisms of antiepileptic drug resistance

  2003influential reference
• Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.

  2003influential reference
• Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)*

  2003influential reference
• Brain Access and Anticonvulsant Efficacy of Carbamazepine, Lamotrigine, and Felbamate in ABCC2/MRP2‐Deficient TR− Rats

  2003influential reference
• Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs

  2002cited by this paper
• Recent developments in treatment of status epilepticus: a review.

  2002cited by this paper
• Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

  2002influential reference
• Are MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?

  2002cited by this paper
• Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice.

  2002cited by this paper
• Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man.

  2002influential reference
• Basic Pharmacology of Valproate

  2002cited by this paper
• In Vivo Evidence for P‐Glycoprotein–Mediated Transport of Phenytoin at the Blood–Brain Barrier of Rats

  2001cited by this paper
• Characterization of the Efflux Transport of 17β-Estradiol-d-17β-glucuronide from the Brain across the Blood-Brain Barrier

  2001cited by this paper
• Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier.

  2001cited by this paper
• Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain

  2001influential reference
• Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study.

  2000influential reference
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000cited by this paper
• A family of drug transporters: the multidrug resistance-associated proteins.

  2000influential reference
• Absorption, distribution, and excretion

  1999influential reference
• Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

  1999cited by this paper
• Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells.

  1998cited by this paper
• Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.

  1998influential reference
• Effect of para-aminohippurate on the efflux of valproic acid from the central nervous system of the rabbit.

  1996cited by this paper
• Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene

  1996cited by this paper
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

  1995cited by this paper
• Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system.

  1994cited by this paper
• Assessment of Valproic Acid Serum–Cerebrospinal Fluid Transport by Microdialysis

  1993cited by this paper
• Practical aspects of using microdialysis for determination of brain interstitial concentrations

  1991influential reference
• Microdialysis in the neurosciences

  1991cited by this paper
• Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

  1990cited by this paper
• Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.

  1989cited by this paper
• Blood–Brain Barrier Transport of Valproic Acid

  1985cited by this paper
• Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport

  1985cited by this paper
• Valproic acid

  1980cited by this paper
• Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.

  1978influential reference
• Distribution of valproate across the interface between blood and cerebrospinal fluid.

  1978influential reference

• Evidence of Sex-Related Pharmacodynamic Differences in Photosensitive Epilepsy Treated with Valproate: Findings from a Retrospective, Observational, Single-Center, Within-Patient, Cohort Study

  2025cites this paper
• In vitro assessment of P-glycoprotein-mediated antiseizure medications efflux in a blood-brain barrier cell model.

  2025cites this paper
• Impact of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms on antiepileptic drug safety and efficacy

  2025cites this paper
• The Impact of P‐Glycoprotein on CNS Drug Efflux and Variability in Response

  2025cites this paper
• Exploring the Dynamics of the ABCB1 Membrane Transporter P-glycoprotein in the Presence of ATP and Active/Non-active Compounds through Molecular Dynamics Simulations.

  2024cites this paper
• Effects of co‐administration of lamotrigine on valproate transfer across the placenta and its brain entry in developing Genetic Absence Epilepsy Rats from Strasbourg (GAERS)

  2024cites this paper
• Tolerability of tariquidar - A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy.

  2024cites this paper
• Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance.

  2023cites this paper
• Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy

  2023cites this paper
• Assessing Liver Effects of Cannabidiol and Valproate Alone and in Combination Using Quantitative Systems Toxicology

  2023cites this paper
• Overexpression of Homer1b/c induces valproic acid resistance in epilepsy

  2022cites this paper
• Neuroprotective effect and herbal-drug pharmacokinetic interaction of Gastrodia elata extract on valproic acid.

  2022cites this paper
• Acyclovir Brain Disposition: Interactions with P-gp, Bcrp, Mrp2, and Oat3 at the Blood–Brain Barrier

  2022cites this paper
• Asociación entre los polimorfismos genéticos de nucleótido único en genes transportadores ABC con la epilepsia farmacorresistente en la población española

  2022cites this paper
• Relaciones de estructura-función en la P-glicoproteína humana (ABCB1): Perspectivas de las simulaciones de dinámica molecular

  2022cites this paper
• Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies

  2022cites this paper
• Genetics and antiepileptic-mood stabilizer treatment response in bipolar disorder: what do we know?

  2021cites this paper
• Entry of antiepileptic drugs (valproate and lamotrigine) into the developing rat brain

  2021cites this paper
• Entry of antiepileptic drugs (valproate and lamotrigine) into the developing rat brain.

  2021cites this paper
• Modulation of the transport of valproic acid through the blood-brain barrier in rats by the Gastrodia elata extracts.

  2021cites this paper
• Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children

  2021cites this paper
• Structure–Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations

  2021cites this paper
• Drug Resistance in Epilepsy: Which Prospect to Tame its Stubbornness?

  2021cites this paper
• Estudio de genes candidatos sobre la efectividad y seguridad de la medicación anticonvulsiva en un grupo de pacientes colombianos afectados de epilepsia

  2020influential citation
• Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain

  2020cites this paper
• Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy

  2020cites this paper
• Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.

  2020cites this paper
• Autophagy associated with the efficacy of valproic acid in PTZ-induced epileptic rats.

  2020cites this paper
• Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?

  2020cites this paper
• P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers

  2020cites this paper
• Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study

  2020cites this paper
• Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy.

  2019cites this paper
• ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.

  2019cites this paper
• RNA-seq analysis of blood of valproic acid-responsive and non-responsive pediatric patients with epilepsy

  2019cites this paper
• Novel Mechanisms of Valproate Hepatotoxicity: Impaired Mrp2 Trafficking and Hepatocyte Depolarization.

  2019influential citation
• Роль носительства однонуклеотидных вариантов генов CYP2D6 и ABCB1 в эффективности терапии препаратами вальпроевой кислоты у пациентов с эпилепсией

  2019cites this paper
• Association between ABCB1 polymorphisms and response to first-generation antiepileptic drugs in a Tunisian epileptic population

  2018cites this paper
• The Beneficial Effects of Medication Reconciliation on Paediatric Patients

  2018cites this paper
• Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy

  2018cites this paper
• The beneficial effects of l-cysteine on brain antioxidants of rats affected by sodium valproate

  2017cites this paper
• BIOLOGICAL MARKERS OF THE ANTIEPILEPTIC DRUGS EFFICACY AND SAFETY: PHARMACOGENETICS AND PHARMACOKINETICS

  2017influential citation
• Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis

  2017influential citation
• Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates

  2017cites this paper
• Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy

  2017cites this paper
• In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2

  2017cites this paper
• Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy

  2017cites this paper
• Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers

  2017cites this paper
• Analysis of the Variables Influencing Valproic Acid Concentration in the Serum and Cerebrospinal Fluid of Chinese Patients After Craniotomy

  2017cites this paper
• Role of P‐glycoprotein inhibitors in children with drug‐resistant epilepsy

  2017cites this paper
• Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?

  2017cites this paper
• Mechanisms of hyperexcitability and efficacy of antiepileptic drugs in hippocampal-entorhinal networks in the Reduced Intensity Status Epilepticus (RISE) model of chronic epilepsy

  2017cites this paper
• Valproic Acid in Patients with Glioma: A Small Review

  2017cites this paper
• Механизмы вальпроат-индуцированного тератогенеза

  2017cites this paper
• Beitrag ATP-abhängiger Transportproteine zur Pharmakoresistenz von Patienten mit mesialer Temporallappenepilepsie

  2016cites this paper
• Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures.

  2016cites this paper
• CELL MODELS FOR STUDYING THE INTERPLAY BETWEEN CONJUGATIVE METABOLISM AND EFFLUX TRANSPORTERS: ESTABLISHING UGT1A1, UGT2B7 AND MRP3 TRANSFECTED MDCK CELL LINES

  2016cites this paper
• Inhibition of p38 mitogen‐activated protein kinase signaling reduces multidrug transporter activity and anti‐epileptic drug resistance in refractory epileptic rats

  2016cites this paper
• ABC Transporters and Drug Resistance in Patients with Epilepsy.

  2016cites this paper
• Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies

  2016cites this paper
• Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.

  2016cites this paper
• Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure

  2016cites this paper
• Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature

  2015cites this paper
• Drug Resistance in Cortical and Hippocampal Slices from Resected Tissue of Epilepsy Patients: No Significant Impact of P-Glycoprotein and Multidrug Resistance-Associated Proteins

  2015cites this paper
• Position and orientational preferences of drug-like compounds in lipid membranes: a computational and NMR approach.

  2015cites this paper
• The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide.

  2015cites this paper
• Pilocarpine-Induced Convulsive Activity Is Limited by Multidrug Transporters at the Rodent Blood-Brain Barrier

  2015cites this paper
• Increasing pro-survival factors within whole brain tissue of Sprague Dawley rats via intracerebral administration of modified valproic acid.

  2015cites this paper
• N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy.

  2014cites this paper
• ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.

  2014cites this paper
• Disease Influence on BBB Transport in Neurodegenerative Disorders

  2014cites this paper
• In vitro transport assays of rufinamide, pregabalin, and zonisamide by human P-glycoprotein.

  2014cites this paper
• Systems biology, complexity, and the impact on antiepileptic drug discovery.

  2014cites this paper
• Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy

  2014cites this paper
• Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.

  2014cites this paper
• Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: a systematic review and meta-analysis.

  2014cites this paper
• Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain

  2014cites this paper
• Hyperammonemia Associated with Valproic Acid Concentrations

  2014cites this paper
• Marked Differences in the Effect of Antiepileptic and Cytostatic Drugs on the Functionality of P-Glycoprotein in Human and Rat Brain Capillary Endothelial Cell Lines

  2014cites this paper
• Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain

  2014cites this paper
• Unique Behavioral Characteristics and microRNA Signatures in a Drug Resistant Epilepsy Model

  2014cites this paper
• Factors affecting the production of nanostructure lipid carriers of valproic acid.

  2013cites this paper
• Pharmacogenetics of Chronic Pain and Its Treatment

  2013cites this paper
• Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study

  2013cites this paper
• Valproate Disturbs the Balance Between Branched and Aromatic Amino Acids in Rats

  2013cites this paper
• Sex related differences on valproic acid pharmacokinetics after oral single dose

  2013cites this paper
• Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: a small-animal PET and in-vitro study

  2013cites this paper
• Potential role for human P‐glycoprotein in the transport of lacosamide

  2013cites this paper
• (R)-[11C]verapamil is selectively transported by murine and human P-glycoprotein at the blood–brain barrier, and not by MRP1 and BCRP

  2013cites this paper
• A systematic review and meta‐analysis of the role of ABCC2 variants on drug response in patients with epilepsy

  2013cites this paper
• [Epilepsy pharmacogenetics : science or fiction?].

  2013cites this paper
• Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy.

  2013cites this paper
• SPECIFIČNOSTI U LIJEČENJU EPILEPTIČKIH NAPADAJA KOD TUMORA MOZGA

  2013cites this paper
• Wybrane farmakokinetyczne interakcje leków w trakcie leczenia padaczki. Część II

  2013cites this paper
• P‐glycoprotein (MDR1/ABCB1)

  2013cites this paper
• A scientific review: mechanisms of valproate-mediated teratogenesis

  2013cites this paper
• Title page Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: a small-animal PET and in-vitro study

  2013cites this paper
• Pharmacogénétique de l’épilepsie - Science ou fiction ?

  2013cites this paper
• Efflux transporters in the blood–brain interfaces – in vitro and in vivo methods and correlations

  2012cites this paper
• Glutathione Efflux and Cell Death

  2012cites this paper
• Psychotropic Drug–Drug Interactions Involving P-Glycoprotein

  2012cites this paper